Zydus Lifesciences Buyback Record Date is 29 May 2026.
Zydus Lifesciences is one of India’s largest pharmaceutical and healthcare companies, engaged in the development, manufacturing, and marketing of generic medicines, specialty products, vaccines, biologics, and consumer wellness products. The company operates across the entire pharmaceutical value chain, from research and active pharmaceutical ingredient (API) manufacturing to finished dosage formulations and commercialisation in global markets.
The company has a strong international presence, with operations spanning more than 50 countries and a portfolio of over 1,300 products. The United States remains its largest market, contributing a significant share of revenue through generic formulations and complex products. Zydus also maintains a strong position in India’s branded formulations market across therapeutic segments such as cardiovascular, gastrointestinal, anti-infectives, pain management, and oncology. Zydus operates multiple manufacturing facilities approved by major global regulators including the USFDA, EMA, and MHRA. Apart from pharmaceuticals, Zydus has a growing consumer wellness portfolio that includes sugar substitutes, skincare, and nutraceutical products, helping diversify its revenue base beyond traditional medicines.
Zydus Lifesciences Buyback Record Date, Other Details
| Zydus Lifesciences Buyback Dates | Coming soon |
| Zydus Lifesciences Buyback Price | INR 1,150 per share |
| Market Price on Buyback Approval | INR 1,018.95 per share |
| Buyback Premium on Market Price | 12.86% |
| Buyback Offer Size (Shares) | 95,65,217 shares |
| Buyback Offer Size (Amount) | INR 1,100 crore |
| Offer Type | Tender |
| Promoter Participation | Nil |
| Face Value | INR 1 per share |
| Listing At | BSE, NSE |
Zydus Lifesciences Buyback Dates (Timeline)
| Board Meeting Intimation for Buyback Proposal | 13 May 2026 |
| Buyback Approval Date | 19 May 2026 |
| Public Announcement of Buyback | Coming soon |
| Zydus Lifesciences Buyback Record Date | 29 May 2026 |
| Buyback Opening Date | Coming soon |
| Buyback Closing Date | Coming soon |
| Cut-off Date to receive completed tender forms by Registrar | Coming soon |
| Verification Date by the Registrar | Coming soon |
| Return of unaccepted shares by Registrar | Coming soon |
| Extinguishment of accepted shares | Coming soon |
Zydus Lifesciences Buyback 2026 Documents
Letter of Offer
Public Announcement
Board Approval
Upcoming Share Buyback
Zydus Lifesciences Buyback Entitlement Ratio
| Shareholder Category | Entitlement Ratio | Entitlement Ratio (in %) |
| Small Shareholders (less than INR 2 Lakh on record date) | – | 3.47* |
| General category (for all other Eligible Shareholders) | – | – |
A small shareholder is defined as a shareholder who holds shares worth less than INR 2,00,000 as of the record date.
Zydus Lifesciences Financial Performance
| FY 2023 | FY 2024 | FY 2025 | |
| Total Income | 17,237 | 19,547 | 23,242 |
| Total Expenses | 13,378 | 14,163 | 16,183 |
| Net Income | 2,092 | 3,973 | 4,673 |
Calculation of Investment in Buyback
| Maximum market value of a shareholder as on record date | INR 2,00,000 |
| Buyback price per share | INR 1,150 |
| Maximum shares for small shareholders (2,00,000/1,150) | 174 shares * |
| The closing price of the stock as of 19 May 2026 | INR 1,018.95** |
| Maximum amount invested in buyback (INR 174 x 1,018.95 shares) | INR 1,77,297.3 |
** For simplicity, we have considered the price on the buyback approval date
Zydus Lifesciences Buyback Acceptance Ratio
| Shares Tendered | Buyback Entitlement | Acceptance ratio | Buyback Profit | Profit in % |
| 174 | 6 | 6 (100%) | 786.3 | 0.44 |
| 174 | 6 | 12 (200%) | 1,572.6 | 0.89 |
| 174 | 6 | 18 (300%) | 2,358.9 | 1.33 |
Registrar of Zydus Lifesciences Buyback 2026
Coming soon
Manager of Zydus Lifesciences Buyback 2026
Coming soon
The Process to Participate in Zydus Lifesciences Buyback
All eligible shareholders of the company who own shares in the physical or demat form on the record date may participate in the buyback offer through their stockbroker. The eligible shareholders who hold the shares in demat form must notify their brokers of the details of the equity shares that they wish to tender in the buyback offer.
The shareholder must transfer the tendered shares to the clearing corporation’s Special account. In turn, the broker would place a buyback order on the stock exchange.
The eligible shareholders who own the shares in physical form must present their broker with the original share certificates and supporting documents. After document verification is complete, the broker places an order on the stock exchange and submits the original share certificate and TRS (Transaction Registration Slip) to the registrar.
Frequently Asked Questions
What are Zydus Lifesciences buyback dates?
Zydus Lifesciences’ buyback opens on June 2026 and closes on June 2026.
Which type of buyback Zydus Lifesciences‘ buyback offer?
Zydus Lifesciences’ buyback is a tender offer.
What is Zydus Lifesciences buyback price?
Zydus Lifesciences’ buyback price is INR 1,150 per share.
What is the Zydus Lifesciences buyback record date?
Zydus Lifesciences’ share buyback record date is 29 May 2026.
How to participate in Zydus Lifesciences share buyback?
Zydus Lifesciences share buyback will be conducted through the tender process and investors who hold the shares on record date can place orders through their broker.
Rajat Bhati has a strong technical background and 5 years of experience in the stock market. He focuses on equity research, technical analysis, IPO valuations, and risk management, helping investors make clearer, data-backed decisions. Today, he works full-time to educate people about the opportunities in IPO market.
